Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.86

-0.57

-0.29

0

Details

Expected EPS

-0.83976

Actual EPS

-0.73

Surprise EPS

0.11

Surprise Percent

+13.07%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.73 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.